SCALINGSCIENTIFICINNOVATION
MIA BIO is creating the infrastructure to make South Florida a world-class biotech hub.
Building the Foundation for Innovation
Initiatives designed to create lasting infrastructure for South Florida's biotech ecosystem.
Ecosystem Mapping
Comprehensive mapping of South Florida's life science & biotech assets (research institutions, companies, talent, and funding) to identify gaps and opportunities in the region.
Learn more
Infrastructure & Labs
Establishing built-to-suit and flex wet/dry lab space, shared research facilities, and innovation districts that give companies the tools they need to scale and thrive in South Florida.
Learn more
Talent & Education
Partnering with universities and training programs to develop the specialized workforce South Florida's biotech sector needs.
Learn more
Why South Florida?
World-class research institutions. A strategic gateway from Latin America to the world. Growing investor interest. Exceptional quality of life. South Florida has all the ingredients and MIA BIO is building the recipe.
Featured News
MIA BIO Explores Demand for Life Science and Biotech Spaces in Miami
December 15, 2025
The initiative is focused on identifying what lab and office space South Florida biotech companies would utilize, helping shape future infrastructure priorities.
Read MoreLatest Updates
View all
April 8, 2026
Philanthropy Fuels Progress: Shaham Gift Propels FIU Medicine and South Florida's Biotech Future
The landmark gift from Helen and Jacob Shaham to Florida International University's Herbert Wertheim College of Medicine represents a transformative investment in the region's life science capabilities, promising to accelerate innovation, attract top talent, and create new opportunities within the burgeoning South Florida biotech ecosystem. This strategic philanthropic commitment underscores a broader trend of private sector and individual support driving public institutions forward, an essential component for sustainable growth in the life sciences.
Read more
March 31, 2026
Bridging Metabolism and Cardiology: GLP-1 Therapy's New Frontier in Atrial Fibrillation
The University of Miami Miller School of Medicine has published groundbreaking research demonstrating that the integration of GLP-1 receptor agonist therapy markedly enhances post-ablation outcomes for individuals suffering from atrial fibrillation. This pivotal finding underscores a burgeoning connection between metabolic and cardiovascular health, offering new therapeutic avenues and reinforcing South Florida's position at the forefront of medical innovation. For scientists, founders, policymakers, and investors, this study highlights critical opportunities for drug repurposing and integrated care models within the life sciences ecosystem.
Read more
March 21, 2026
Breaking Through: How FAU’s Discovery of Cellular Tunnels Could Redefine Huntington’s Treatment
A groundbreaking study from Florida Atlantic University highlights a novel mechanism in neurodegeneration, emphasizing South Florida’s growing influence in life science research.
Read more
Be Part of Something Foundational
Join our founding network and help shape what South Florida's biotech and life science future looks like.